GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » 3-Year EBITDA Growth Rate

Pilulka Lekarny AS (XPRA:PINK) 3-Year EBITDA Growth Rate : -190.90% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS 3-Year EBITDA Growth Rate?

Pilulka Lekarny AS's EBITDA per Share for the six months ended in Dec. 2023 was Kč-33.73.

During the past 3 years, the average EBITDA Per Share Growth Rate was -190.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pilulka Lekarny AS was -190.90% per year. The lowest was -190.90% per year. And the median was -190.90% per year.


Competitive Comparison of Pilulka Lekarny AS's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's 3-Year EBITDA Growth Rate falls into.



Pilulka Lekarny AS 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Pilulka Lekarny AS  (XPRA:PINK) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Pilulka Lekarny AS 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pilulka Lekarny AS Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023